EP Patent

EP0794805A1 — Dose indicating device

Assigned to AstraZeneca AB · Expires 1997-09-17 · 29y expired

What this patent protects

Dose indicating device to be provided on an inhalator, preferably a breath-actuated dry-powder inhalator, designed for containing multiple doses of a medicament containing an active substance, the inhalator having operating means comprising a manoeuvering element for loading one …

USPTO Abstract

Dose indicating device to be provided on an inhalator, preferably a breath-actuated dry-powder inhalator, designed for containing multiple doses of a medicament containing an active substance, the inhalator having operating means comprising a manoeuvering element for loading one dose of the medicament to a dosing unit and providing said dose in a position for inhalation, wherein the dose indicating device is provided as a separate unit to be placed on the manoeuvering element of the inhalator and in that it comprises a first element to be provided on and around the outer wall surface of the manoeuvering element of the inhalator; a second element provided on and around the outer surface of said first element, the second element being rotatable relative to said first element; interrupting means provided on said first and second elements limiting the length of the relative movement between said elements; and registration/indication for registration of the movement of said manoeuvering element and thereby the feeding of a dose to the inhalation channel when the inhalator is activated for inhalation said registration/indication means being provided as parts of said first and second elements.

Drugs covered by this patent

Patent Metadata

Patent number
EP0794805A1
Jurisdiction
EP
Classification
Expires
1997-09-17
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.